AstraZeneca’s newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says July 23, 2021 Auto Bot News 0 AstraZeneca’s newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says nhigginsdunn Fri, 07/23/2021 – 14:46